Clinical Trial Update: A Study to Learn About the Safety of TALZENNA in People With Prostate Cancer.

View source ↗

Summary

This ClinicalTrials.gov study aims to evaluate the safety of TALZENNA (talazoparib) in people with prostate cancer and is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Talzenna (talazoparib)

Snippet

Sponsor: Pfizer | Conditions: Prostate Cancer | Status: ACTIVE_NOT_RECRUITING